Study of cerebrospinal fluid in patients with hematologic malignancies
Keywords:
biomarkers, flow cytometry, hematologic malignancies, cerebrospinal fluid, polymerase chain reaction, central nervous system.Abstract
Introduction: Infiltration of the central nervous system by malignant cells constitutes a serious complication of some hematological malignancies, mainly acute leukemias and aggressive lymphomas.
Objective: To summarize the scientific basis and clinical significance of cerebrospinal fluid study methods for the diagnosis and follow-up of neuromeningeal infiltration in patients with hematologic malignancies.
Methods: Information was searched during April 2021 in PubMed, ScienceDirect and SciELO databases. Publications were selected based on their typology, timeliness, scope, and study limitations.
Conclusions: The cytomorphological study of cerebrospinal fluid is considered the standard method for the diagnosis and follow-up of neuromeningeal infiltration. Flow cytometry is more sensitive for the detection of occult infiltration than conventional cytology, but there are still reservations about its clinical significance. The sensitivity of other molecular studies such as the use of PCR and biomarker detection is also investigated.
Downloads
References
1. Pui CH, Thiel E. Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Sem Oncology. 2009;36(supl 2):S2-16. DOI: https://doi.org/10.1053/j.seminoncol.2009.05.002
2. Mauermann ML. Neurologic complications of lymphoma, leukemia, and paraproteinemias. Continuum (Minneap Minn). 2017;23(3):669-90. DOI: https://doi.org/10.1212/con.0000000000000468
3. Girard S, Fenneteau O, Mestrallet F, Troussard X, Lesesve JF. Recommendations for cerebrospinal fluid examination in acute leukemia. Ann Biol Clin. 2017;75(5):503-12. DOI: https://doi.org/10.1684/abc.2017.1250
4. Lenk L, Alsadeq A, Schewe DM. Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data. Cancer Metastasis Rev. 2020;39(1):173-87. DOI: https://doi.org/10.1007/s10555-020-09848-z
5. Deak D, Gorcea-Andronic N, Sas V, Teodorescu P, Constantinescu C, Iluta S, et al. A narrative review of central nervous system involvement in acute leukemias. Ann Transl Med. 2021;9(1):68. DOI: https://doi.org/10.21037/atm-20-3140
6. Thastrup M, Marquart HV, Levinsen M, Grell K, Abrahamsson J, Albertsen BK, et al. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: A Nordic Society of Pediatric Hematology and Oncology study. Leukemia. 2020;34(2):336-46. DOI: https://doi.org/10.1038/s41375-019-0570-1
7. Yousafzai YM, Smith L, Smith A, Bhatti S, Gardiner M, Cousins A, et al. Use of quantitative polymerase chain reaction (qPCR) for the diagnosis and monitoring of CNS leukaemia. Leuk Res. 2019;87:106232. DOI: https://doi.org/10.1016/j.leukres.2019.106232
8. Ikonomidou C. Cerebrospinal fluid biomarkers in childhood leukemias. Cancers. 2021;13(3):438. DOI: https://doi.org/10.3390/cancers13030438
9. Frishman L, Izraeli S. Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy. Br J Haematol. 2017;176(2):157-67. DOI: https://doi.org/10.1111/bjh.14411
10. Yao H, Price TT, Cantelli G, Ngo B, Warner MJ, Olivere L, et al. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature. 2018;560(7716):55-60. DOI: https://doi.org/10.1038/s41586-018-0342-5
11. Zhou F, Wen Y, Jin R, Chen H. New attempts for central nervous infiltration of pediatric acute lymphoblastic leukemia. Cancer Metastasis Rev. 2019;38(4):657-71. DOI: https://doi.org/10.1007/s10555-019-09827-z
12. Del Principe MI, Buccisano F, Soddu S, Maurillo L, Cefalo M, Piciocchi A, et al. Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome. Semin Hematol. 2018;55(4):209-14. DOI: https://doi.org/10.1053/j.seminhematol.2018.02.006
13. Hernández CC, Pino LSM, García GA, Carnot UJ, Muñío PJ, Cepero LK; et al. Caracterización de los linfomas no Hodgkin con afectación del sistema nervioso. Rev Acta Méd. 2018 [acceso 05/04/2021];19(3). Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=84187
14. Villegas CA, Suárez A, Torres G, González T, Martínez LY, Gracia EA, et al. Supervivencia de pacientes con linfoma no-Hodgkin y síntomas neurológicos según inmunofenotipo del líquido cefalorraquídeo. Rev Cub Hematol Inmunol Hemoter. 2019 [acceso 05/04/2021];35(3):e1068. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892019000300008
15. Murthy H, Anasetti C, Ayala E. Diagnosis and management of leukemic and lymphomatous meningitis. Cancer Control. 2017;24(1):33-41. DOI: https://doi.org/10.1177/107327481702400105
16. Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Eur J Haematol. 2016;96(5):447-60. DOI: https://doi.org/10.1111/ejh.12722
17. Barredo J, Ritchey AK. Controversies in the management of central nervous system leukemia. Pediatr Hematol Oncol. 2010;27(5):329-32. DOI: https://doi.org/10.3109/08880011003758422
18. Yeh TC, Liang DC, Hou JY, Jaing TH, Lin DT, Yang CP, et al. Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 study. Cancer. 2018;124(23):4538-47. DOI: https://doi.org/10.1002/cncr.31758
19. Wu JM, Georgy MF, Burroughs FH, Weir EG, Rosenthal DL, Ali SZ. Lymphoma, leukemia, and pleiocytosis in cerebrospinal fluid: is accurate cytopathologic diagnosis possible based on morphology alone? Diagn Cytopathol. 2009;37(11):820-4. DOI: https://doi.org/10.1002/dc.21110
20. Crespo E, López X, Higuera J, Vega B. Diagnosis of acute leukemia in cerebrospinal fluid (CSF-acute leukemia). Curr Oncol Rep. 2012;14(5):369-78. DOI: https://doi.org/10.1007/s11912-012-0248-6
21. Rahimi J, Woehrer A. Overview of cerebrospinal fluid cytology. Handb Clin Neurol. 2017;145:563-71. DOI: https://doi.org/10.1016/B978-0-12-802395-2.00035-3
22. Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008;9(3):257-68. DOI: https://doi.org/10.1016/S1470-2045(08)70070-6
23. Seo JY, Lee SH, Kim HJ, Yoo KH, Koo HH, Cho YG, et al. MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia. Ann Lab Med. 2012;32(4):289-93. DOI: https://doi.org/10.3343/alm.2012.32.4.289
24. Canovi S, Campioli D. Accuracy of flow cytometry and cytomorphology for the diagnosis of meningeal involvement in lymphoid neoplasms: A systematic review. Diagn Cytopathol. 2016;44(10):841-56. DOI: https://doi.org/10.1002/dc.23539
25. Jaime JC, Borrego MF, Jiménez RA, Méndez N, Salazar R, Fernández LT, et al. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia. Int J Lab Hematol. 2018;40(2):169-74. DOI: https://doi.org/10.1111/ijlh.12760
26. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drénou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94(1):182-8. DOI: https://doi.org/10.1002/cyto.b.21403
27. Gajjar A, Harrison PL, Sandlund JT, Rivera GK, Ribeiro RC, Rubnitz JE. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. 2000;96(10):3381-4. DOI: https://doi.org/10.1182/blood.V96.10.3381
28. Triana Y, Marsán V. Aplicaciones de la citometría de flujo en el estudio de los síndromes linfoproliferativos crónicos. Rev Cub Hematol Inmunol Hemoter. 2020 [acceso 18/04/2021];36(1):e1137. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-02892020000100002&script=sci_arttext&tlng=en
29. Mitri Z, Siddiqui MT, El Rassi F, Holden JT, Heffner LT, Langston A, et al. Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma. Leuk Lymphoma. 2014;55(7):1498-500. DOI: https://doi.org/10.3109/10428194.2013.852667
30. Babusíková O, Zelezníková T. The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells. Neoplasma. 2004 [acceso 18/04/2021];51(5):345-51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15640938
31. Del Principe MI, Buzzatti E, Piciocchi A, Forghieri F, Bonifacio M, Lessi F, et al. Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network. Haematol. 2021;106(1):39-45. DOI: https://doi.org/10.3324/haematol.2019.231704
32. Egan PA, Elder PT, Deighan WI, O'Connor SJM, Alexander HD. Multiple myeloma with central nervous system relapse. Haematol. 2020;105(7):1780-90. DOI: https://doi.org/10.3324/haematol.2020.248518
33. Dias AL, Higashi F, Peres ALM, Cury P, Crusoé EQ, Hungria VTM. Multiple myeloma and central nervous system involvement: experience of a Brazilian center. Rev Bras Hematol Hemoter. 2018;40(1):30-6. DOI: https://doi.org/10.1016/j.bjhh.2017.09.004
34. Ren H, Zou Y, Zhao Y, Li J, Han X, He J, et al. Cerebrospinal fluid cytological diagnosis in multiple myeloma with leptomeningeal involvement: a report of two cases. Diagn Cytopathol. 2017;45(1):66-8. DOI: https://doi.org/10.1002/dc.23600
35. Popov A, Henze G, Verzhbitskaya T, Roumiantseva J, Lagoyko S, Khlebnikova O, et al. Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia. J Cancer Res Clin Oncol. 2019;145:1331-9. DOI: https://doi.org/10.1007/s00432-019-02886-3
36. Pine SR, Yin C, Matloub YH, Sabaawy HE, Sandoval C, Levendoglu-Tugal O, et al. Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction. J Molec Diag. 2005;7(1):127-32. DOI: https://doi.org/10.1016/S1525-1578(10)60018-9
37. Scrideli CA, Queiroz RP, Takayanagui OM, Bernardes JE, Tone LG. Polymerase chain reaction on cerebrospinal fluid cells in suspected leptomeningeal involvement in childhood acute lymphoblastic leukemia: comparison to cytomorphological analysis. Diagn Mol Pathol. 2003;12(3):124-7. DOI: https://doi.org/10.1097/00019606-200309000-00002
38. Cancela CSP, Assumpcao JG, Paula FDF, Murao M, Viana MB, Oliveira BM. Use of the polymerase chain reaction as a complementary method for the detection of central nervous system involvement in children and adolescents with acute lymphoblastic leukemia. Clin Lab. 2018;64(1):205-9. DOI: https://doi.org/10.7754/clin.lab.2017.170622
39. Gajendra S, Das RR, Sharma R. Isolated central nervous system (CNS) relapse in paediatric acute promyelocytic leukaemia: A systematic review. J Clin Diagn Res. 2017;11(3):XE05-8. DOI: https://doi.org/10.7860/JCDR/2017/24196.9572
40. Biojone E, Queiróz P, Valera ET, Odashima NS, Takayanagui OM, Viana MB, et al. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia. Leuk Lympho. 2012;53(1):89-95. DOI: https://doi.org/10.3109/10428194.2011.606939
41. Xiao F, Lv S, Zong Z, Wu L, Tang X, Kuang W, et al. Cerebrospinal fluid biomarkers for brain tumor detection: clinical roles and current progress. Am J Transl Res. 2020 [acceso 18/04/2021];12(4):1379-96. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32355549
42. Kopková A, ? ána J, Večeřa M, Fadrus P, Lipina R, Smrčka M, et al. MicroRNAs in cerebrospinal fluid as biomarkers in brain tumor patients. Klin Onkol. 2019;32(3):181-6. DOI: https://doi.org/10.14735/amko2019181
43. Mikhael NL, Seif MA, Hassab H, Megahed EA. Evaluation of multiplexed biomarkers in assessment of CSF infiltration in pediatric acute lymphoblastic leukemia. Int J Hematol Oncol. 2019;8(3). DOI: https://doi.org/10.2217/ijh-2019-0008
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes: Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons (CC-BY-NC 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista. Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista. Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
Como Revista Cubana de Investigaciones Biomédicas forma parte de la red SciELO, una vez los artículos sean aceptados para entrar al proceso editorial (revisión), estos pueden ser depositados por parte de los autores, si estan de acuerdo, en SciELO preprints, siendo actualizados por los autores al concluir el proceso de revisión y las pruebas de maquetación.
